Commission proposes to extend transition periods for certain IVDs, gradual roll-out of Eudamed and an information obligation in case of interruption of supply

In January 2024, the European Commission proposed to amend existing IVDR, MDR, and EUDAMED regulations.

Commission proposes to extend transition periods for certain IVDs, gradual roll-out of Eudamed and an information obligation in case of interruption of supply

In continuation of our news update

Med-Di-Dia and Global Regulatory Services (GRS) are thrilled to announce a fireside chat-style LinkedIn Live session. This session will delve into discussing a proposal and sharing an ideal strategy for its hopeful adoption by the European Commission, ultimately transforming into a regulation. 

Details of the session:

Moderated by Suzanne Rose from Global Regulatory Services, this session promises to be enlightening as she extracts valuable insights from Dr. Shahram Ahmadi, RAQA Specialist at Med-Di-Dia, and Jacob Skinner, RAQA Specialist at Global Regulatory Services.

Don't miss this opportunity to be part of a significant conversation! We welcome your questions in advance, which can be submitted via our web page - https://tally.so/r/3qA6b8



Looking for something specific?